Moleculin Biotech
MBRX
MBRX
19 hedge funds and large institutions have $1.53M invested in Moleculin Biotech in 2024 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
66% less capital invested
Capital invested by funds: $4.44M → $1.53M (-$2.92M)
Holders
19
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$19.5K | |
| 2 | +$4.05K | |
| 3 | +$1.64K | |
| 4 |
NS
NBC Securities
Birmingham,
Alabama
|
+$1K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$934 |
Top Sellers
| 1 | -$386K | |
| 2 | -$111K | |
| 3 | -$61.3K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$55.5K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$46K |